COMMUNICATION
|
doi:10.20944/preprints202312.0417.v3
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
Hepatocellular carcinoma; HBV-related; anti-PD1 antibody; ropeginterferon alfa-2b; animal HBV model; clinical trial
Online: 8 December 2023 (12:37:22 CET)